| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.059 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |